Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Clinical trial NCT04450732 · UNKNOWN

Trial details

NCT number: NCT04450732
Sponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-positive Breast Cancer HER2-positive Biliary Tract Cancer HER2-Positive Salivary Gland Carcinomas HER2-Positive Advanced Solid Tumor

Start date: 2020-07-07
Primary completion: 2024-03-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.